...
首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
【24h】

The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib

机译:局部区域治疗的病人的影响晚期肝细胞癌治疗与索拉非尼

获取原文
获取原文并翻译 | 示例
           

摘要

Background & aims: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population.
机译:背景与目的:还不知道的局部区域(LRTx)的疗法索拉非尼在索拉非尼改善预后晚期患者的肝细胞癌(HCC)。评估LRTx的影响在这个人口。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号